Literature DB >> 2254456

Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.

P Diem1, J B Redmon, M Abid, A Moran, D E Sutherland, J B Halter, R P Robertson.   

Abstract

Successful pancreas transplantation in type I diabetic patients restores normal fasting glucose levels and biphasic insulin responses to glucose. However, virtually no data from pancreas recipients are available relative to other islet hormonal responses or hormonal counterregulation of hypoglycemia. Consequently, glucose, glucagon, catecholamine, and pancreatic polypeptide responses to insulin-induced hypoglycemia and to stimulation with arginine and secretin were examined in 38 diabetic pancreas recipients, 54 type I diabetic nonrecipients, and 26 nondiabetic normal control subjects. Glucose recovery after insulin-induced hypoglycemia in pancreas recipients was significantly improved. Basal glucagon levels were significantly higher in recipients compared with nonrecipients and normal subjects. Glucagon responses to insulin-induced hypoglycemia were significantly greater in the pancreas recipients compared with nonrecipients and similar to that observed in control subjects. Glucagon responses to intravenous arginine were significantly greater in pancreas recipients than that observed in both the nonrecipients and normal subjects. No differences were observed in epinephrine responses during insulin-induced hypoglycemia. No differences in pancreatic polypeptide responses to hypoglycemia were observed when comparing the recipient and nonrecipient groups, both of which were less than that observed in the control subjects. Our data demonstrate significant improvement in glucose recovery after hypoglycemia which was associated with improved glucagon secretion in type I diabetic recipients of pancreas transplantation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254456      PMCID: PMC329838          DOI: 10.1172/JCI114936

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Hormonal responses to insulin infusion in diabetes mellitus.

Authors:  L V Campbell; E W Kraegen; H Meler; L Lazarus
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

2.  Elevated plasma glucagon levels in cirrhosis of the liver.

Authors:  J Marco; J Diego; M L Villanueva; M Diaz-Fierros; I Valverde; J M Segovia
Journal:  N Engl J Med       Date:  1973-11-22       Impact factor: 91.245

3.  Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion.

Authors:  J E Gerich; M Lorenzi; E Tsalikian; J H Karam
Journal:  Diabetes       Date:  1976-01       Impact factor: 9.461

4.  Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones.

Authors:  G Boden; G A Reichard; R D Hoeldtke; I Rezvani; O E Owen
Journal:  N Engl J Med       Date:  1981-11-12       Impact factor: 91.245

5.  Plasma human pancreatic polypeptide responses to administered secretin: effects of surgical vagotomy, cholinergic blockade, and chronic pancreatitis.

Authors:  B Glaser; A I Vinik; A A Sive; J C Floyd
Journal:  J Clin Endocrinol Metab       Date:  1980-06       Impact factor: 5.958

6.  Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients.

Authors:  P Diem; M Abid; J B Redmon; D E Sutherland; R P Robertson
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

7.  Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

Authors:  J E Gerich; M Langlois; C Noacco; J H Karam; P H Forsham
Journal:  Science       Date:  1973-10-12       Impact factor: 47.728

8.  Lack of glucagon response to hypoglycemia in diabetic autonomic neuropathy.

Authors:  T D Maher; R J Tanenberg; B Z Greenberg; J E Hoffman; R P Doe; F C Goetz
Journal:  Diabetes       Date:  1977-03       Impact factor: 9.461

9.  Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man.

Authors:  J W Benson; D G Johnson; J P Palmer; P L Werner; J W Ensinck
Journal:  J Clin Endocrinol Metab       Date:  1977-03       Impact factor: 5.958

10.  Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon.

Authors:  J B Jaspan; K S Polonsky; M Lewis; J Pensler; W Pugh; A R Moossa; A H Rubenstein
Journal:  Am J Physiol       Date:  1981-03
View more
  29 in total

Review 1.  Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.

Authors:  Philip E Cryer
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

Review 2.  Assessment of islet function following islet and pancreas transplantation.

Authors:  Emily C Dy; David M Harlan; Kristina I Rother
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

3.  Time-related, cross-sectional and prospective follow-up of pancreatic endocrine function after pancreas allograft transplantation in type 1 (insulin-dependent) diabetic patients.

Authors:  R P Robertson; P Diem; D E Sutherland
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

4.  Pancreatic Islet Cell Transplantation: A new era in transplantation.

Authors:  G L Warnock; R V Rajotte
Journal:  Can Fam Physician       Date:  1992-07       Impact factor: 3.275

Review 5.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

6.  Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation.

Authors:  Luisa M Rodríguez; Richard J Knight; Rubina A Heptulla
Journal:  Diabetes Technol Ther       Date:  2010-05       Impact factor: 6.118

7.  Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients.

Authors:  L Luzi; A Battezzati; G Perseghin; E Bianchi; I Terruzzi; D Spotti; S Vergani; A Secchi; E La Rocca; G Ferrari
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 8.  Clinical islet transplantation.

Authors:  Dixon B Kaufman; William L Lowe
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

9.  Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation.

Authors:  R Landgraf; J Nusser; R L Riepl; F Fiedler; W D Illner; D Abendroth; W Land
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

10.  Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.

Authors:  Benjamin A Cooperberg; Philip E Cryer
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.